Dolby Laboratories [DLB] vs Copart [CPRT] Detailed Stock Comparison

Dolby Laboratories Inc.

NYSE
Loading...

Copart Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Dolby Laboratories Inc. wins in 9 metrics, Copart Inc. wins in 11 metrics, with 0 ties. Copart Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dolby Laboratories Inc. Copart Inc. Better
P/E Ratio (TTM) 26.28 21.22 Copart Inc.
Price-to-Book Ratio 2.39 3.32 Dolby Laboratories Inc.
Debt-to-Equity Ratio 1.56 0.98 Copart Inc.
PEG Ratio -1.24 -2.12 Dolby Laboratories Inc.
EV/EBITDA 15.70 14.15 Copart Inc.
Profit Margin (TTM) 17.97% 33.76% Copart Inc.
Operating Margin (TTM) 20.95% 34.65% Copart Inc.
EBITDA Margin (TTM) 20.95% 34.65% Copart Inc.
Return on Equity 9.46% 17.13% Copart Inc.
Return on Assets (TTM) 5.26% 10.99% Copart Inc.
Free Cash Flow (TTM) $430.26M $1.23B Copart Inc.
Dividend Yield 2.07% N/A N/A
1-Year Return -24.85% -36.34% Dolby Laboratories Inc.
Price-to-Sales Ratio (TTM) 4.63 7.08 Dolby Laboratories Inc.
Enterprise Value $5.61B $27.51B Copart Inc.
EV/Revenue Ratio 4.19 5.96 Dolby Laboratories Inc.
Gross Profit Margin (TTM) 87.54% 43.94% Dolby Laboratories Inc.
Revenue per Share (TTM) $14 $5 Dolby Laboratories Inc.
Earnings per Share (Diluted) $2.47 $1.59 Dolby Laboratories Inc.
Beta (Stock Volatility) 0.86 1.14 Dolby Laboratories Inc.
Short % of Float 8.57% 4.07% Copart Inc.

Dolby Laboratories Inc. vs Copart Inc. Stock Performance Analysis

Loading Price Chart...

DLB
CPRT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dolby Laboratories Inc.-1.29%-1.38%-6.03%-15.21%-17.20%-13.60%
Copart Inc.-1.65%-7.61%-8.83%-21.13%-21.88%-19.65%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dolby Laboratories Inc.-24.85%-33.11%-42.48%16.64%22.44%147.28%
Copart Inc.-36.34%-25.54%4.83%437.21%1,095.99%1,922.84%

Performance & Financial Health Analysis: Dolby Laboratories Inc. vs Copart Inc.

MetricDLBCPRT
Market Information
Market Cap i$6.02B$32.80B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i537,0108,554,909
90 Day Avg. Volume i611,7008,488,133
Last Close$54.89$30.35
52 Week Range$52.45 - $77.00$29.97 - $51.15
% from 52W High-28.71%-40.66%
All-Time High$104.74 (May 03, 2021)$64.38 (Nov 25, 2024)
% from All-Time High-47.59%-52.86%
Growth Metrics
Quarterly Revenue Growth-0.03%-0.04%
Quarterly Earnings Growth-0.21%-0.10%
Financial Health
Profit Margin (TTM) i0.18%0.34%
Operating Margin (TTM) i0.21%0.35%
Return on Equity (TTM) i0.09%0.17%
Debt to Equity (MRQ) i1.560.98
Cash & Liquidity
Book Value per Share (MRQ)$27.15$10.16
Cash per Share (MRQ)$6.75$5.30
Operating Cash Flow (TTM) i$420.22M$1.80B
Levered Free Cash Flow (TTM) i$367.37M$1.04B
Dividends
Last 12-Month Dividend Yield i2.07%N/A
Last 12-Month Dividend i$1.38N/A

Valuation & Enterprise Metrics Analysis: Dolby Laboratories Inc. vs Copart Inc.

MetricDLB (Apr 24, 2026)CPRT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i26.2821.22
Forward P/E i14.0120.08
PEG Ratio i-1.24-2.12
Price to Sales (TTM) i4.637.08
Price to Book (MRQ) i2.393.32
Market Capitalization
Market Capitalization i$6.02B$32.80B
Enterprise Value i$5.61B$27.51B
Enterprise Value Metrics
Enterprise to Revenue i4.195.96
Enterprise to EBITDA i15.7014.15
Risk & Other Metrics
Beta i0.861.14
Book Value per Share (MRQ) i$27.15$10.16

Financial Statements Comparison: Dolby Laboratories Inc. vs Copart Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDLB (2025)CPRT (2025)
Revenue/Sales i1.35B4.65B
Cost of Goods Sold i160.13M2.55B
COGS % of Revenue i11.9%54.8%
Gross Profit i1.19B2.10B
Gross Margin i88.1%45.2%
Research & Development i261.79MN/A
Operating Income (EBIT) i279.97M1.70B
Operating Margin i20.8%36.5%
EBITDA i393.57M1.91B
EBITDA Margin i29.2%41.2%
Pre-Tax Income i303.49M1.90B
Pre-Tax Income % of Revenue i22.5%40.8%
Income Tax i46.99M347.22M
Income Tax % of Revenue i3.5%7.5%
Net Income (Profit) i256.49M1.55B
Profit Margin i19.0%33.3%

Balance Sheet & Liquidity Metrics

MetricDLB (2025)CPRT (2025)
Cash & Equivalents i701.89M2.78B
Total Current Assets i1.39B5.75B
Total Current Assets % of Revenue i102.9%123.8%
Total Current Liabilities i437.79M683.28M
Total Current Liabilities % of Revenue i32.4%14.7%
Long-Term Debt i28.49M83.87M
Long-Term Debt % of Revenue i2.1%1.8%
Total Shareholders Equity i2.63B9.21B
Retained Earnings i2.63B8.09B
Retained Earnings % of Revenue i195.3%174.2%
Property, Plant & Equipment i267.63M99.71M

Cash Flow Statement Comparison

MetricDLB (2025)CPRT (2025)
Operating Cash Flow i432.40M1.85B
Operating Cash Flow % of Revenue i32.1%39.8%
Capital Expenditures i-36.35M-537.16M
Free Cash Flow i430.26M1.23B
FCF Margin i31.9%26.5%
Debt Repayment iN/A-49,000
Common Stock Repurchase i-162.23MN/A

Short Interest & Institutional Ownership Analysis

MetricDLBCPRT
Shares Short i3.91M31.76M
Short Ratio i6.023.74
Short % of Float i8.57%4.07%
Shares Outstanding i95.53M963.29M
Float Shares i60.20M882.95M
% Held by Insiders i1.28%8.66%
% Held by Institutions i99.28%86.43%
% Held by Public i-0.56%4.91%

Dividend Analysis & Yield Comparison: Dolby Laboratories Inc. vs Copart Inc.

MetricDLBCPRT
Last 12-Month Dividend i$1.38N/A
Last 12-Month Dividend Yield i2.07%N/A
3-Year Avg Annual Dividend i$1.26N/A
3-Year Avg Dividend Yield i0.41%N/A
3-Year Total Dividends i$3.78N/A
Ex-Dividend DateFeb 10, 2026N/A